CIN- L67120MH1995PLC084899


Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Lasa Supergenerics Ltd.

NSE : LASAEQ BSE : 540702 ISIN CODE : INE670X01014Industry : Chemicals - Speciality

News

  • Lasa Supergenerics - Structural Digital Database 18 Jul 2026 | 12:02 | Dion Global

    SDD certificate for the quarter ended June 2026more...

  • Lasa Supergenerics - Trading Window 29 Jun 2026 | 16:02 | Dion Global

    Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) ...more...
  • Lasa Supergenerics - Disclosure under SEBI Takeover Regulations 02 Jun 2026 | 09:41 | Dion Global

    Omkar Herlekar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A...more...

  • Lasa Supergenerics - Updates 30 May 2026 | 17:26 | Dion Global

    Lasa Supergenerics Limited has informed the Exchange regarding Annual Secretarial Complaince report as on March 31 2026 .more...
  • Lasa Supergenerics - Integrated Filing As On March 31, 2026 29 May 2026 | 21:17 | Dion Global

    Integrated filings as on 31st march 2026more...

  • Lasa Supergenerics - Related Party Transaction As On 31St March 2026 29 May 2026 | 21:10 | Dion Global

    Related party transaction as on 31 st march 2026more...
  • Lasa Supergenerics - Board Meeting Outcome for Revised Outcome Of Board Meeting For Quarter Ended 31 March 2026 29 May 2026 | 20:18 | Dion Global

    Revised outcome of board meeting for quarter ended 31 march 2026more...

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting For Quarter Ended March 31 St 2026 29 May 2026 | 18:19 | Dion Global

    Outcome of board meeting for the quarter ended 31st march 2026more...
  • Lasa Supergenerics - Board Meeting Intimation for Quarter And Year Ended March 31St , 2026 19 May 2026 | 13:33 | Dion Global

    Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider an...more...

  • Lasa Supergenerics has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026 12 May 2026 | 16:40 | Dion Global

    As of March 2026 53.65% is owned by Indian Promoters and 46.35% by Public. Top Promoter holding highest number of shares of Lasa Supergeneri...more...
  • Lasa Supergenerics - Certificate under SEBI (Depositories and Participants) Regulations, 2018 12 May 2026 | 11:58 | Dion Global

    Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • Lasa Supergenerics - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 May 2026 | 11:52 | Dion Global

    Certificate Reg 74 (5) of SEBI (DP) Regulations 2018 as on 31st March 2026more...
  • Lasa Supergenerics - Structural Digital Database 16 Apr 2026 | 17:50 | Dion Global

    SDD Compliance Certificatemore...

  • Lasa Supergenerics - Updates 16 Apr 2026 | 16:55 | Dion Global

    Lasa Supergenerics Limited has informed the Exchange regarding Declaration with respect to non -applicability of Large Entities .more...
  • Lasa Supergenerics - Declaration With Respect To Non -Applicability Of Large Entities 16 Apr 2026 | 16:48 | Dion Global

    Declaration with respect to non- applicability of Large Entitiesmore...

  • Lasa Supergenerics - Trading Window 30 Mar 2026 | 18:02 | Dion Global

    Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) ...more...
  • Lasa Supergenerics - Clarification - Financial Results 11 Mar 2026 | 12:45 | Dion Global

    The Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Li...more...

  • Lasa Supergenerics posts Q3 net loss of Rs 2.55 cr 13 Feb 2026 | 16:10 | Dion Global

    The company reported standalone net loss during the quarter stood at Rs 2.55 crore compared to net profit of Rs 5.49 crore in the previous y...more...
  • Lasa Supergenerics - Integrated Filing- Financial 13 Feb 2026 | 16:04 | Dion Global

    Integrated filingmore...

  • Lasa Supergenerics - Integrated Filing- Financial 13 Feb 2026 | 16:01 | Dion Global

    Integated filingmore...
DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
More
Sensex76835.781.02%
NSE Index23995.950.96%
B500DIVL503512.831.08%
BSE 1000 10837.51.07%
BSE 100LCTMC9048.710.99%
BSE Auto 60690.551.53%
More

Commodity

Gold1438290.41%
Silver2243570.69%
Copper1347.5230.43%
Crude Oil862234.45%
Lead206.3553.53%
Mentha Oil133324.88%
Nickel1676.9118.66%
More

Currency

USD/INR 96.54(0.06 %)
GBP/INR 129.18(0.04 %)
EUR/INR 110.32(0.21 %)
JPY/INR 0.59(-0.25 %)
CAD/INR 68.21(0.00 %)
HKD/INR 12.27(-0.02 %)
More


Announcement Calendar

Previous monthJuly 2026Next month
MonTueWedThuFriSatSun
29301
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
12
3456789
Upcoming

BOARD MEETINGS
Company Name : Alembic Pharma.
Date : 04-08-2026

More

Latest Videos

Watch More Videos